YARS antibody (C-Term)
Quick Overview for YARS antibody (C-Term) (ABIN630055)
Target
See all YARS (Yars) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Specificity
- YARS antibody was raised against the C terminal of YARS
-
Purification
- Purified
-
Immunogen
- YARS antibody was raised using the C terminal of YARS corresponding to a region with amino acids QVEPLDPPAGSAPGEHVFVKGYEKGQPDEELKPKKKVFEKLQADFKISEE
-
-
-
-
Application Notes
-
WB: 2.5 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
YARS Blocking Peptide, (ABIN5617056), is also available for use as a blocking control in assays to test for specificity of this YARS antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of YARS antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- YARS (Yars) (Tyrosyl-tRNA Synthetase (Yars))
-
Alternative Name
- YARS
-
Background
- Aminoacyl-tRNA synthetases catalyze the aminoacylation of tRNA by their cognate amino acid. Because of their central role in linking amino acids with nucleotide triplets contained in tRNAs, aminoacyl-tRNA synthetases are thought to be among the first proteins that appeared in evolution. Tyrosyl-tRNA synthetase belongs to the class I tRNA synthetase family. Cytokine activities have also been observed for the human tyrosyl-tRNA synthetase, after it is split into two parts, an N-terminal fragment that harbors the catalytic site and a C-terminal fragment found only in the mammalian enzyme. The N-terminal fragment is an interleukin-8-like cytokine, whereas the released C-terminal fragment is an EMAP II-like cytokine.
-
Molecular Weight
- 58 kDa (MW of target protein)
Target
-